Influenza vaccine group direction (VGD) template
VGD template for administering inactivated influenza vaccine or live attenuated influenza vaccine in line, with the national seasonal flu vaccination programme.
Applies to England
Documents
Details
This vaccine group direction (VGD) template supports the administration of either inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV) as part of the national seasonal influenza vaccination programme.
The Influenza VGD version 1.0 is valid from 1 September 2026 to 31 March 2027.
This VGD template should be used with reference to current national guidance, the Green Book and the relevant Summary of Product Characteristics (SPC) for the vaccine.